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Introduction
Staphylococcus aureus is a major human pathogen. It has the ability to adapt to 
a biofilm mode of growth in response to the host environment, and this is 
crucial for its leading role in device-related infections and chronic infections. 
However, little is known about stepwise changes in virulence expression and 
metabolism from inception of infection to establishment of chronic biofilm 
infections.
Aim
To identify and compare the in vivo transcriptional changes of a clinical S. aureus 
strain (SAU060112) during infection development in vitro, in a guinea pig biofilm 
model and in a patient with an infected prosthetic joint. 
Results
Principal component analysis showed 
 In vivo gene expression profiles were distinctly different from in vitro
cultures of S. aureus.
 The guinea pig data grouped together with a patient case of prosthetic 
joint infection.
Reference: Xu et al. (2016). In vivo gene expression in a Staphylococcus aureus prosthetic joint infection characterized by RNA 
sequencing and metabolomics: a pilot study. BMC Microbiology, 16(1), 80. 
Function of Staphylococcus aureus biofilm - studied in 
vitro, in guinea pigs and in a patient
Lone Heimann Larsen1, Yijuan Xu2,3, Henrik C. Schønheyder1,4 and
Trine Rolighed Thomsen2,3
1. Department of Clinical Microbiology, Aalborg University Hospital, Aalborg, Denmark
2. Biotech, Danish Technological Institute, Aarhus, Denmark
3. Department of Chemistry and Bioscience, Aalborg University
4. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Methods
Total RNA extraction (PowerLyser® 
Ultraclean® Tissue & Cells RNA Isolations 
Kit)
Removal of human RNA 
(MICROBEnrichTM)
Sequencing library prep (Illumina® 
TruSeq® Stranded mRNA Library Prep )
Sequencing on Illumina
Removal of bacterial rRNA
(RiboZero rRNA Removal Kit (Bacteria) )
Bioinformatics analysis on CLC 
genomic workbench  
Conclusions
 In vivo S. aureus gene expression profiles are distinct from in vitro profiles.
 S. aureus adjusts its virulence expression and adapts to hypoxic and acidic 
environment during infection development. 
 During prosthetic joint infection in the patient S. aureus sustained on a 
versatile human-cell-based diet consisting of amino acids, glycans and 
nucleosides in the hypoxic joint fluid.
 Many, but not all, of the known virulence factor genes were upregulated in 
vivo compared with in vitro.
 The applied guinea pig model is suitable for studying S. aureus pathogenesis.  
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Differential gene expression in the guinea pig model showed 
 Virulence genes: 16 were upregulated at infection day 3 compared to  
infection day 7 and 9. 
 Metabolic pathways: the arginine deiminase pathway and the urea 
degradation pathway were upregulated at day 7 and 9 compared to day 3 
and Treat14. 
 This indicated decreased virulence expression and a response to the acidic 
environment during infection development.
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Figure 2 All enzymes in the pathway for 
amino acid degradation are highly 
expressed in the patient sample
Figure 3 Free amino acids were 
abundant in the infected joint fluid 
from the patient
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Figure 1 Principal component analysis of all transcriptome profiles
A controlled study of infection development in guinea pig model:
